Calprotectin Testing Market

Calprotectin Testing Market Outlook (2023 to 2033)

The calprotectin testing market is capturing a valuation of USD 201.1 billion in 2023 and is predicted to reach USD 360.2 billion by 2033. The market is registering a CAGR of 6% during the forecast period.

The market is driven by various factors, including:

• Prevalence of Inflammatory Bowel Disease: Rising inflammatory bowel disease among patients.
• Rising Demand for Non-invasive Diagnostic Tools: Patients are increasing the demand for calprotectin testing to detect chronic disease and enhance the procedure of non-invasive diagnostics.
• Advanced Technology: The growing technology to improve the reliability and accuracy of calprotectin testing. For instance, new testing devices are developed to detect the patient's disease and provide rapid results.
• Growing Awareness: Healthcare providers growing awareness among consumers about the benefits of testing equipment is advancing the market opportunities.
• Rising Healthcare Sector: The healthcare sector is rapidly growing due to the development of effective and efficient healthcare services. This calprotectin testing help reduces costs, manage chronic disease effectively, and detect early symptoms.

Lack of Awareness and Low Standardized Product Limit the Market Growth

Various factors restrain market growth are:

• Lack of Standardization: The low-quality calprotectin testing, limited features, and cut-off values. This equipment affects the reliability and accuracy of detecting patients' chronic conditions.
• High Cost: The manufacturers develop expensive non-invasive diagnostic tools compared to other testing tools. It may limit the adoption of calprotectin testing devices in several healthcare sectors. The developing countries decline to adopt these testing due to their budget limits.
• Alternative Diagnostic Tools: Healthcare providers choose other diagnostic tools due to their unavailability and high costs.
• Limited Awareness: Patients are unaware of calprotectin testing and its benefits. Several healthcare providers are still not adopting this tool due to unavailability, which may also affect the demand.

Attributes	Details
Market CAGR (2023 to 2033)	6%
Market Valuation (2023)	USD 201.1 billion
Market Valuation (2033)	USD 360.2 billion

Calprotectin Testing Market, 2018 to 2022 Historical Sales, Compared to 2023 to 2033 Future Outlook

The market experienced steady growth between 2018 and 2022. The market was valued at USD 190.5 billion in 2022, with a CAGR of 5.3% between 2018 and 2022. A surge in chronic patients, increasing demand for non-invasive diagnostic tools, and growing advanced technology have driven the market size.

The market has faced various challenges, such as limited awareness, low-quality tools, and high competition. The various end-use sectors, such as hospitals, specialty clinics, and others, continuously grow the market revenue during the forecast period. Healthcare manufacturers are developing advanced tools to detect and monitor patients' chronic conditions.

• Short Term (2023 to 2026): Increasing old age population, rising demand for reliable diagnostic tools, and growing chronic diseases drive the global market size. Developed countries are experimenting with providing accurate and effective tools that help to detect patients' conditions quickly.
• Medium Term (2026 to 2029): The rising advanced technologies, innovation of testing equipment for better healthcare services, and growing awareness drive the market growth. The innovation of advanced non-invasive diagnostic tools is expected to fuel the market size in this time frame.
• Long Term (2029 to 2033): The increasing research and development activities and government support to expand the healthcare sector propel market opportunities. Diagnostic laboratories are key to developing advanced testing equipment to treat patients.

The Top Categories Advancing the Global Market are

Calprotectin ELISA Test Kits are Highly Sought-after in the Global Market

Based on test kits, calprotectin ELISA test kits are estimated to dominate the global market by securing a share of 90.46% during the forecast period. The laboratory's adoption of calprotectin ELISA test kits is increasing to detect and qualify biological samples. These kits help measure the calprotectin level, advancing the market growth.

The demand for calprotectin ELISA test kits is rising due to their ability to collect multiple samples and ease to use with high sensitivity. The growing popularity of these devices among healthcare professionals is fueling the market size. The manufacturers are distributors offering multiple kits with their respective uses, and benefits are advancing the market opportunities.

Which Indication Category Leads the Global Market?

Based on indication, irritable bowel syndrome is anticipated to lead the global market by registering a share of 79% during the forecast period. Irritable bowel syndrome is a prime indication segment that affects the large intestine. The rising prevalence of irritable bowel syndrome surges the demand for calprotectin testing.

The Top Countries that Influenced the Global Market are

Countries	Projected Value (2023 to 2033)
United States	25.7%
Germany	3%
Japan	3.1%
Australia	5.6%
China	7.8%
India	8.7%
United Kingdom	6.2%

Growing Advanced Testing Technology Upsurge the United States Market

The United States is estimated to dominate the global market by securing a share of 25.7% during the forecast period. The increasingly advanced testing technology and growing patient awareness fuel the country's market size. The growth in gastrointestinal disorders and chronic diseases is increasing the adoption of calprotectin testing in the healthcare sector.

Healthcare manufacturers are developing advanced testing equipment to monitor patients' diseases and enhance the performance of checkups. These manufacturers offer a variety of testing tools to monitor the diagnostic condition of patients. Additionally, provide better services expanding the United States calprotectin testing market.

How Does Germany Drive the Global Market Revenue?

Germany is one of the significant countries in the global market that secure a share of 3% during the forecast period. Various factors are driving the German market are:

• Growing Healthcare Infrastructure: Germany is known for its strong healthcare infrastructure. The healthcare providers focus on developing calprotectin testing devices to detect and prevent early symptoms.
• Rising Inflammatory Bowel Disease: The increasing incidence of inflammatory bowel disease is growing in Germany's market size. The country is rapidly growing in chronic diseases with the huge inflammatory bowel disease rates.
• Increasing Awareness: Germany continuously grows awareness about calprotectin testing and its essential uses and quick monitoring system. Physicians prefer to increase the adoption of these testing tools for their patients.
• Growing Research and Development: The leading manufacturers in Germany, such as Calpro AS and others, are contributing a vital role in the market. The key companies invest in research and development activities to improve reliability and accuracy.

Growing Aging Population Upsurge Japan Market

Japan is one of the significant countries in the global market, capturing a share of 3.1% during the forecast period. The rising prevalence of inflammatory bowel disease is fueling the market growth in Japan. For Instance, around 2,00,000 people have been affected by inflammatory bowel disease recently.

The aging population and chronic patients are increasing the demand for calprotectin testing in Japan. The surging demand for diagnostic tests among patients is increasing the adoption of these testing tools. The manufacturers in Japan are investing in research and development activities to upsurge the medical field. Several Japanese companies are improving testing devices to provide accuracy in testing.

The increasing aging population and strong research activities are innovating unique products that satisfy healthcare providers' and patients' requirements. These factors are contributing to uplifting Japan's calprotectin testing market.

How can Manufacturers Expand the Global Market?

With the following steps, the manufacturers can expand the global market are:

• Developing Innovative Products: Manufacturers can expand the market through their innovation to offer better, cost-effective, and more reliable testing devices. They provide easy-to-use and accurate result tools to enhance the patient testing experience.
• Provide Competitive Prices: The manufacturers develop calprotectin testing products at competitive prices by reducing costs and increasing production. These testing tools are more efficient as compared to other diagnostic testing tools. Therefore, manufacturers are increasing their production processes to expand the market revenue.
• Distribution Networks: Manufacturers increase their distribution networks to enhance their reach to attract more consumers. They are partnering with distributors and promote their products by advertising and marketing to reach relevant customers. Through these, the manufacturers build trust and transparency in their products.
• Training and Supports: Manufacturers train healthcare providers on their newly launched products. It helps them use it efficiently, building trust and loyalty to their brand.
• Conduct Clinical Trials: Clinical trial is an effective solution to check the effectiveness of the testing tool. It helps them to build credibility among patients and healthcare providers.

These are a few steps on which the manufacturers can expand the global market.

Competitive Landscape

Several key players highly influence the market. The key players are developing unique and advanced testing devices to detect and monitor patients' chronic diseases. They are investing in research and development activities and offer better solutions with advanced technologies.

These players are fueling the healthcare sector by increasing their services as per consumers' needs. The players are adopting various marketing tactics to enhance the global market size. These marketing strategies are collaborations, acquisitions, mergers, partnerships, agreements, and product launches.

Other Essential Players in the Market are:

• Actim Oy
• Calpro AS
• BÜHLMANN Laboratories AG
• EagleBio
• CerTest Biotec S.L.
• EUROIMMUN Medizinische Labordiagnostika AG
• Boditech Med Inc.
• Biohit Oyj
• American Laboratory Products Company, Ltd.
• DIAsource ImmunoAssays S.A
• R-Biopharm AG.
• Abbexa
• AccuBio Tech Co., Ltd.
• Screen Italia Srl.
• Hangzhou Biotest Biotech Co., Ltd
• Thermo Fisher Scientific
• Epitope Diagnostics, Inc.
• Elabscience Biotechnology Inc
• Vitassay Healthcare, S.L.U.
• Beckman Coulter Inc.
• DiaSorin

Recent Development in the Global Market are:

• In 2021, BÜHLMANN Laboratories AG announced its newly launched calprotectin point-of-care test, Quantum Blue fCAL turbo.
• In 2020, Biohit Healthcare launched its calprotectin ELISA kit test for laboratory sample purposes to measure the level of calprotectin.
• In 2021, Calpro AS announced its newly launched test CalproSmart. It provides a digital and fully automated test to monitor patients' diagnosis and monitor inflammatory bowel disease.
• In 2021, Alpha Laboratories Ltd launched the fCAL turbo assay that quickly and accurately measures calprotectin levels.

Scope of Report

Attribute	Details
Forecast Period	2023 to 2033
Historical Data Available for	2018 to 2022
Market Analysis	USD billion for Value
Key Countries Covered	The United States, The United Kingdom, Japan, India, China, Australia, Germany
Key Segments Covered	Test Kit, Sample, Indication, End Use, Region
Key Companies Profiled	Actim Oy; Calpro AS; BÜHLMANN Laboratories AG; EagleBio; CerTest Biotec S.L.; EUROIMMUN Medizinische Labordiagnostika AG; Boditech Med Inc.; Biohit Oyj; American Laboratory Products Company, Ltd.; DIAsource ImmunoAssays S.A; R-Biopharm AG.; Abbexa; AccuBio Tech Co., Ltd.; Screen Italia Srl.; Hangzhou Biotest Biotech Co., Ltd; Thermo Fisher Scientific; Epitope Diagnostics, Inc.; Elabscience Biotechnology Inc; Vitassay Healthcare, S.L.U.; Beckman Coulter Inc.; DiaSorin
Report Coverage	Market Forecast, Company Share Analysis, Competition Intelligence, DROT Analysis, Market Dynamics and Challenges, and Strategic Growth Initiatives
Customization & Pricing	Available upon Request

Calprotectin Testing Market by Category

By Test Kits:

• Calprotectin ELISA Test Kits
• Calprotectin Rapid Testing Kits

By Sample:

• Stool, Blood Serum/Plasma
• Other Biological Samples

By Indication:

• Irritable Bowel Syndrome
• Ulcerative Colitis
• Crohn’s Disease
• Colorectal Cancer

By End User:

• Hospitals
• Diagnostic Laboratories
• Specialty Clinics

By Region:

• North America
• Europe
• Latin America
• Asia Pacific
• The Middle East and Africa

Frequently Asked Questions

What is the market value in 2023?

The 2023 market value is USD 201.1 billion.

What is the growth rate through 2033?

Until 2033, the market will rise at a 6% CAGR.

What will be the market value in 2033?

By 2033, the market will total USD 360.2 billion.

What drives market growth?

Rising gastrointestinal disorder diagnoses propel market growth.

Which region leads the market growth?

North America will be a highly lucrative market.